Food News and Research

RSS

New 'Pesticide-Induced Diseases Database' tracks published epidemiologic and real world exposure studies

Links to pesticide exposure are being found in a growing number of studies that evaluate the causes of preventable diseases -- including asthma, autism and learning disabilities, birth defects and reproductive dysfunction, diabetes, Parkinson's and Alzheimer's diseases, and several types of cancer. A new database, released today, tracks published epidemiologic and real world exposure studies.

19 Aug 2010

FDA accepts to review Bristol-Myers Squibb's ipilimumab for melanoma

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA.

19 Aug 2010

FDA grants orphan drug designation to ImmunoGen's lorvotuzumab mertansine for small-cell lung cancer

ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).

19 Aug 2010

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.

19 Aug 2010

FDA grants 510(k) clearance to Aesculap's A-Fix Spinal System

The Aesculap Implant Systems A-Fix Spinal System received 510(k) clearance under K100802 by the U.S. Food and Drug Administration (FDA) on July 20, 2010.

18 Aug 2010

Also in Global Health News: Global Fund in El Salvador; World Bank investment in Nepal; Bed nets in Africa; Ukraine caps grain exports

Global Post examines how the Global Fund to Fight AIDS, Tuberculosis and Malaria is impacting HIV/AIDS care and human rights in El Salvador. The article profiles Carla, a Salvadorian transvestite who tested positive for HIV in jail and was able to receive anti-retroviral (ARV) treatment through a program supported by the Global Fund, which the article calls a "revolutionary model."

18 Aug 2010

NASA to host LAUNCH: Health forum focusing on health issues

NASA will host LAUNCH: Health, a global forum focusing on health issues, at the agency's Kennedy Space Center in Florida from Oct. 30-31. NASA, the U.S. Agency for International Development, the U.S. Department of State, and NIKE are partnering on LAUNCH to identify, showcase and support innovative approaches to sustainability challenges through a series of forums.

18 Aug 2010

Intellect Neurosciences locks database of OXIGON Phase 1b clinical trial for Alzheimer's disease

Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has locked the database of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON™ (OX1).

18 Aug 2010

USPTO grants Collegium second patent for tamper-resistant DETERx formulation platform

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.

18 Aug 2010

Biogen Idec, Knopp Neurosciences enter license agreement for KNS-760704 ALS drug candidate

Biogen Idec and Knopp Neurosciences today announced they have entered into an exclusive, worldwide license agreement under which Biogen Idec will develop and commercialize KNS-760704 (dexpramipexole) for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and potentially other indications.

18 Aug 2010

Open Society Foundations to provide additional $5M to help flood-hit areas in Pakistan

In response to unprecedented devastation and human suffering caused by the flooding in Pakistan, the Open Society Foundations today announced it would give an additional $5 million to its foundation there to respond to the humanitarian crisis.

18 Aug 2010

Regenicin acquires worldwide exclusive license to know-how technology

Regenicin, Inc., a development stage biotechnology company, announced today that it has completed an initial $3.25 million funding in conjunction with its acquisition of a worldwide exclusive license to know-how technology controlled by Lonza Walkersville ("Lonza Agreement").

18 Aug 2010

FDA grants BSD Medical marketing clearance for MicroThermX Microwave Ablation System

BSD Medical Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.

18 Aug 2010

FDA grants orphan drug designation to NephRx's lead product NX001

NephRx Corporation today announced that the U.S. Food and Drug Administration has granted orphan drug designation to its lead product NX001 for the prevention of delayed graft function in renal transplant recipients. NX001 is a kidney growth factor peptide that has demonstrated good safety and promising efficacy in two animal models of acute renal failure.

18 Aug 2010

World Bank to provide $900M in emergency funding for Pakistan floods, country's High Commissioner provides rough damage estimate

The World Bank on Monday "pledged to reroute money from other projects to provide $900 million in emergency funding to help Pakistan" with its flood recovery efforts, the New York Times reports (Ellick, 8/17).

18 Aug 2010

Study finds pharmaceuticals as a two-tier market for producing 'lemons' and serious harm

The pharmaceutical industry is a "market for lemons," a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe than consumers are led to believe, according to an analysis that will be presented at the 105th Annual Meeting of the American Sociological Association.

18 Aug 2010

New research explores effects of radiation on human bone after stereotactic radiosurgery

New research holds promise for the thousands of people whose cancer has spread to their bones.A common treatment for such patients is radiation surgery even though very little is known about radiosurgery's impact on bone strength, says Edmond Richer, associate professor of engineering at Southern Methodist University in Dallas.

18 Aug 2010

USAID, NASA, NIKE and State Department partner to address humanity's sustainability challenges

The U.S. Agency for International Development (USAID), NASA, the U.S. Department of State, and NIKE, Inc. have partnered on a unique initiative called LAUNCH. The idea behind LAUNCH is to identify, showcase and support innovative approaches to humanity's sustainability challenges through a series of forums, each focused on a specific sustainability challenge. The second event in the LAUNCH series, LAUNCH: Health, will focus specifically on health issues related to the first 20 years of life.

18 Aug 2010

Study shows increase in IL-6 secretion can reduce Tarceva sensitivity to treat lung tumor cells

One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time.

18 Aug 2010

Tips to maintain and improve brain health

While there are still mysteries surrounding the fundamental process of memory, research has revealed activities that may enhance memory and promote overall brain health. John H. Byrne, Ph.D., professor and chairman of the Department of Neurobiology and Anatomy at the University of Texas Health Science Center at Houston (UTHealth) Medical School, studies the neuronal and molecular mechanisms underlying learning and memory. Here are three tips he offers for maintaining and improving brain health.

18 Aug 2010

Food News and Research

New 'Pesticide-Induced Diseases Database' tracks published epidemiologic and real world exposure studies

FDA accepts to review Bristol-Myers Squibb's ipilimumab for melanoma

FDA grants orphan drug designation to ImmunoGen's lorvotuzumab mertansine for small-cell lung cancer

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

FDA grants 510(k) clearance to Aesculap's A-Fix Spinal System

Also in Global Health News: Global Fund in El Salvador; World Bank investment in Nepal; Bed nets in Africa; Ukraine caps grain exports

NASA to host LAUNCH: Health forum focusing on health issues

Intellect Neurosciences locks database of OXIGON Phase 1b clinical trial for Alzheimer's disease

USPTO grants Collegium second patent for tamper-resistant DETERx formulation platform

Biogen Idec, Knopp Neurosciences enter license agreement for KNS-760704 ALS drug candidate

Open Society Foundations to provide additional $5M to help flood-hit areas in Pakistan

Regenicin acquires worldwide exclusive license to know-how technology

FDA grants BSD Medical marketing clearance for MicroThermX Microwave Ablation System

FDA grants orphan drug designation to NephRx's lead product NX001

World Bank to provide $900M in emergency funding for Pakistan floods, country's High Commissioner provides rough damage estimate

Study finds pharmaceuticals as a two-tier market for producing 'lemons' and serious harm

New research explores effects of radiation on human bone after stereotactic radiosurgery

USAID, NASA, NIKE and State Department partner to address humanity's sustainability challenges

Study shows increase in IL-6 secretion can reduce Tarceva sensitivity to treat lung tumor cells

Tips to maintain and improve brain health

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News